Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis

References

• WillisRAThe Spread of Tumours in the Human BodyLondonJ&A. Churchill1934
   Google Scholar
• HadfieldGThe dormant cancer cellBr Med J19542488860761013190204
   PubMedGoogle Scholar
• GossPEChambersAFDoes tumor dormancy offer a therapeutic target?Nat Rev Cancer20101087187721048784
   PubMed Web of Science ®Google Scholar
• Aguirre-GhisoJAModels, mechanisms and clinical evidence for cancer dormancyNat Rev Cancer200771183484617957189
   PubMed Web of Science ®Google Scholar
• RakhraKBachireddyPZabuawalaTCD4+T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivationCancer Cell201018548549821035406
   PubMed Web of Science ®Google Scholar
• KarevaIEscape from tumor dormancy and time to angiogenic switch as mitigated by tumor-induced stimulation of stromaJ Theor Biol2016395112226826487
   PubMedGoogle Scholar
• OsisamiMKellerETMechanisms of metastatic tumor dormancyJ Clin Med20132313615026237067
   PubMedGoogle Scholar
• RankinEBGiacciaAJHypoxic control of metastasisScience2016352628217518027124451
   PubMed Web of Science ®Google Scholar
• SynnestvedtMBorgenEWistEDisseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention studyBMC Cancer20121261623259667
   PubMedGoogle Scholar
• SosaMSBragadoPAguirre-GhisoJAMechanisms of disseminated cancer cell dormancy: an awakening fieldNat Rev Cancer20141461162225118602
   PubMed Web of Science ®Google Scholar
• HanselGSchonlebeJHaroskeGLate recurrence (10 years or more) of malignant melanoma in south-east Germany (Saxony). A single-centre analysis of 1881 patients with a follow-up of 10 years or moreJ Eur Acad Dermatol Venereol201024783383620070457
   PubMedGoogle Scholar
• LianidouESMarkouAStratiAThe role of CTCs as tumor biomarkersAdv Exp Med Biol201586734136726530376
   PubMed Web of Science ®Google Scholar
• WuXLTuQFaureGGalletPKohlerCBittencourt MdeCDiagnostic and prognostic value of circulating tumor cells in head and neck squamous cell carcinoma: a systematic review and meta-analysisSci Rep201662021026831813
   PubMedGoogle Scholar
• EylesJPuauxALWangXTumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanomaJ Clin Invest201012062030203920501944
   PubMed Web of Science ®Google Scholar
• SchlimokGFunkeIHozmannBMicrometastatic cancer cells in bone marrow: in vitro detection with anticytokeratin and in vivo labeling with anti-17-1A monoclonal antibodiesProc Natl Acad Sci U S A19878423867286762446326
   PubMed Web of Science ®Google Scholar
• RiethmullerGJohnsonJPMonoclonal antibodies in the detection and therapy of micrometastatic epithelial cancersCurr Opin Immunol1992456476551418733
   PubMedGoogle Scholar
• LohrJGAdalsteinssonVACibulskisKWhole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancerNat Biotechnol201432547948424752078
   PubMed Web of Science ®Google Scholar
• MagbanuaMJDasRPolavarapuPParkJWApproaches to isolation and molecular characterization of disseminated tumor cellsOncotarget2015631307153072926378808
   PubMedGoogle Scholar
• FluegenGAvivar-ValderasAWangYPhenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironmentsNat Cell Biol201719212013228114271
   PubMed Web of Science ®Google Scholar
• PantelKBrakenhoffRHBrandtBDetection, clinical relevance and specific biological properties of disseminating tumor cellsNat Rev Cancer20088532934018404148
   PubMed Web of Science ®Google Scholar
• MsakiAPastoACurtarelloMA hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer modelOncotarget2016722330813309527105499
   PubMedGoogle Scholar
• ZhangLRiethdorfSWuGMeta-analysis of the prognostic value of circulating tumor cells in breast cancerClin Cancer Res201218205701571022908097
   PubMedGoogle Scholar
• AggarwalCMeropolNJPuntCJRelationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancerAnn Oncol201324242042823028040
   PubMed Web of Science ®Google Scholar
• ZhangTArmstrongAJClinical utility of circulating tumor cells in advanced prostate cancerCurr Oncol Rep2016181326700506
   PubMedGoogle Scholar
• KulasingheAPerryCJovanovicLNelsonCPunyadeeraCCirculating tumour cells in metastatic head and neck cancersInt J Cancer2015136112515252325111594
   PubMed Web of Science ®Google Scholar
• NicholsACLowesLESzetoCCDetection of circulating tumor cells in advanced head and neck cancer using the cell search systemHead Neck201234101440144422076949
   PubMed Web of Science ®Google Scholar
• CamptonDERamirezABNordbergJJHigh-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence stainingBMC Cancer20151536025944336
   PubMed Web of Science ®Google Scholar
• SchattonTMurphyGFFrankNYIdentification of cells initiating human melanomasNature2008451717634534918202660
   PubMed Web of Science ®Google Scholar
• ChenXLiXZhaoBDormancy activation mechanism of oral cavity cancer stem cellsTumour Biol20153675551555925722113
   PubMedGoogle Scholar
• Ricci-VitianiLLombardiDGPilozziEIdentification and expansion of human colon-cancer-initiating cellsNature2007445712311111517122771
   PubMed Web of Science ®Google Scholar
• AdikrisnaRTanakaSMuramatsuSIdentification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agentsGastroenterology2012143123424522510202
   PubMedGoogle Scholar
• MoghbeliMMoghbeliFForghanifardMMAbbaszadeganMRCancer stem cell detection and isolationMed Oncol20143196925064729
   PubMed Web of Science ®Google Scholar
• DionneLKDriverERWangXJHead and neck cancer stem cells: from identification to tumor immune networkJ Dent Res201594111524153126253189
   PubMedGoogle Scholar
• CohenSJPuntCJIannottiNRelationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancerJ Clin Oncol200826193213322118591556
   PubMed Web of Science ®Google Scholar
• YuMTingDTStottSLRNA sequencing of pancreatic circulating tumour cells implicates WNT signaling in metastasisNature2012487740851051322763454
   PubMed Web of Science ®Google Scholar
• TamWLWeinbergRAThe epigenetics of epithelial-mesenchymal plasticity in cancerNat Med201319111438144924202396
   PubMed Web of Science ®Google Scholar
• FukusumiTIshiiHKonnoMCD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinomaBr J Cancer2014111350651424874475
   PubMedGoogle Scholar
• ZuoJHZhuWLiMYActivation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherinJ Cell Biochem201111292508251721557297
   PubMed Web of Science ®Google Scholar
• KupfermanMEJiffarTEI-NaggarATrkB induces EMT and has a key role in invasive of head and neck squamous cell carcinomaOncogene201029142047205920101235
   PubMedGoogle Scholar
• JohnMADohadwalaMLuoJProinflammatory mediators upregulate snail in head and neck squamous cell carcinomaClin Cancer Res200915196018602719789323
   PubMedGoogle Scholar
• KangYPantelKTumor cell dissemination: emerging biological insights from animal models and cancer patientsCancer Cell201323557358123680145
   PubMed Web of Science ®Google Scholar
• ChafferCLWeinbergRAA perspective on cancer cell metastasisScience201133160241559156421436443
   PubMed Web of Science ®Google Scholar
• MascréGDekoninckSDrogatBDistinct contribution of stem and progenitor cells to epidermal maintenanceNature2012489741525726222940863
   PubMedGoogle Scholar
• NaikPPDasDNPandaPKImplications of cancer stem cells in developing therapeutic resistance in oral cancerOral Oncol20166212213527865365
   PubMed Web of Science ®Google Scholar
• ChakrabortyCChinKYDasSmiRNA-regulated cancer stem cells: understanding the property and the role of miRNA in carcinogenesisTumour Biol20163710130391304827468722
   PubMedGoogle Scholar
• YataKBederLBTamagawaSMicroRNA expression profiles of cancer stem cells in head and neck squamous cell carcinomaInt J Oncol20154741249125626323893
   PubMedGoogle Scholar
• SunZHuWXuJKaufmannAMAlbersAEMicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitroInt J Oncol20154741339135026323460
   PubMedGoogle Scholar
• MasudaMWakasakiTTohSStress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?Am J Cancer Res2016661149116627429838
   PubMedGoogle Scholar
• Oeztuerk-WinderFVenturaJJThe many faces of p38 mitogen-activated protein kinase in progenitor/stem cell differentiationBiochem J20114451110
   Google Scholar
• SosaMSAvivar-ValderasABragadoPWenHCAguirre-GhisoJAERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual diseaseClin Cancer Res201117185850585721673068
   PubMedGoogle Scholar
• CheryLLamHMColemanICharacterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathwaysOncotarget20145209939995125301725
   PubMedGoogle Scholar
• BarkanDGreenJEChambersAFExtracellular matrix: a gatekeeper in the transition from dormancy to metastatic growthEur J Cancer20104671181118820304630
   PubMed Web of Science ®Google Scholar
• MazarAPAhnRWO’HalloranTVDevelopment of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinicCurr Pharm Des201117191970197821711234
   PubMed Web of Science ®Google Scholar
• XueAXueMJacksonCSmithRCSuppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signalingInt J Biochem Cell Biol2009418–91731173819433314
   PubMedGoogle Scholar
• BragadoPEstradaYParikhFTGF-β2 dictates disseminated tumor cell fate in target organs through TGF-β-RIII and p38α/β signalingNat Cell Biol201315111351136124161934
   PubMedGoogle Scholar
• SuiXKongNYeLp38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agentsCancer Lett2014344217417924333738
   PubMed Web of Science ®Google Scholar
• ChattergjeeMvan GolenKLFarnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and RhoC GTPase activity and induces a dormant phenotypeInt J Cancer20111291616920824700
   PubMedGoogle Scholar
• LotanTHicksonJSourisJc-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulationCancer Res20086872166217518381422
   PubMedGoogle Scholar
• KnopekeMTRitschdorffETClarkRBuilding on the foundation of daring hypotheses: using the MKK4 metastasis suppressor to develop models of dormancy and metastatic colonizationFEBS Lett2011585203159316521925502
   PubMedGoogle Scholar
• JoHJiaYSubramanianKKCancer cell-derived clusterin modulates the phosphatidylinositol 3′-kinase-Akt pathway through attention of insulin-like growth factor 1 during serum deprivationMol Cell Biol2008284285429918458059
   PubMedGoogle Scholar
• ScheweDMAguirre-GhisoJAATF6alpha-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivoProc Natl Acad Sci U S A200810530105191052418650380
   PubMed Web of Science ®Google Scholar
• TouilYSegardPOstynPMelanoma dormancy in a mouse model is linked to GILZ/FOXO3A-dependent quiescence of disseminated stem-like cellsSci Rep201663040527465291
   PubMedGoogle Scholar
• HumtsoeJOKramerRHDifferential epidermal growth factor receptor signaling regulates anchorage-independent growth by modulation of the PI3K/AKT pathwayOncogene20102981214122619935697
   PubMed Web of Science ®Google Scholar
• ChenHKoJMWongVCLTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinomaCancer Lett20123251899822743615
   PubMedGoogle Scholar
• ZhuHLuoHShenZHuXSunLZhuXTransforming growth factor-β1in carcinogenesis, progression, and therapy in cervical cancerTumour Biol2016377075708327010470
   PubMedGoogle Scholar
• QinXYanMZhangJTGFβ3-mediated induction of Periostin facilitates head and neck cancer growth and is associated with metastasisSci Rep201662058726857387
   PubMedGoogle Scholar
• SosaMSParikhFMaiaAGNR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmesNat Commun20156617025636082
   PubMed Web of Science ®Google Scholar
• YumotoKEberMRWangJAxl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrowSci Rep201663652027819283
   PubMedGoogle Scholar
• GaoHChakrabortyGLee-LimAPThe BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sitesCell2012150476477922901808
   PubMed Web of Science ®Google Scholar
• WendtMKTaylorMASchiemannBJSchiemannWPDown-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancerMol Biol Cell201122142423243521613543
   PubMed Web of Science ®Google Scholar
• DenysHDeryckeLHendrixADifferential impact of TGF-beta and EGF on fibroblast differentiation and invasion reciprocally promote colon cancer cell invasionCancer Lett2008266226327418423981
   PubMedGoogle Scholar
• BarkanDKleinmanHSimmonsJLInhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeletonCancer Res200868156241625018676848
   PubMed Web of Science ®Google Scholar
• KobayashiAOkudaHXingFBone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in boneJ Exp Med2011208132641265522124112
   PubMedGoogle Scholar
• BuijsJTHenriquezNVvan OverveldPGvan der HorstGten DijkePvan der PluijmGTGF-beta and BMP7 interactions in tumour progression and bone metastasisClin Exp Metastasis200724860961718008174
   PubMedGoogle Scholar
• NaYRSeokSHKimDJBone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasisCancer Sci2009100112218222519735263
   PubMedGoogle Scholar
• FangWTFanCCLiSMDownregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinomaInt J Cancer2014135480981924477565
   PubMedGoogle Scholar
• SchofieldRThe relationship between the spleen colony-forming cell and the haemopoietic stem cellBlood Cells197841–2725747780
   PubMedGoogle Scholar
• ShiozawaYPedersenEAHavensAMHuman prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrowJ Clin Invest201112141298131221436587
   PubMed Web of Science ®Google Scholar
• LuXMuEWeiYVCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging alpha4beta1-positive osteoclast progenitorsCancer Cell201120670171422137794
   PubMed Web of Science ®Google Scholar
• GhiaurGYegnasubramanianSPerkinsBRegulation of human hematopoietic stem cell self-renewal by the microenvironment’s control of retinoic acid signalingProc Natl Acad Sci U S A201311040161211612624043786
   PubMedGoogle Scholar
• LindeNFluegenGAguirre-GhisoJAThe relationship between dormant cancer cells and their microenvironmentAdv Cancer Res2016132457127613129
   PubMed Web of Science ®Google Scholar
• JungYDeckerAMWangJEndogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrowOncotarget2016718256982571127028863
   PubMedGoogle Scholar
• JungYShiozawaYWangJPrevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironmentNeoplasia201214542943922745589
   PubMedGoogle Scholar
• ShiozawaYPedersenEAPatelLRGAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow nicheNeoplasia201012211612720126470
   PubMed Web of Science ®Google Scholar
• CackowskiFCEberMRRheeJMer tyrosine kinase regulates disseminated prostate cancer cellular dormancyJ Cell Biochem2017118489190227753136
   PubMedGoogle Scholar
• TaichmanRSPatelLRBedenisRGAS6 receptor status is associated with dormancy and bone metastatic tumor formationPLoS One201384e6187323637920
   PubMed Web of Science ®Google Scholar
• LuDChenSTanXFra-1 promotes breast cancer chemosensitivity by driving cancer stem cells from dormancyCancer Res201272143451345622586064
   PubMedGoogle Scholar
• KimJKJungYWangJTBK1 regulates prostate cancer dormancy through mTOR inhibitionNeoplasia20131591064107424027431
   PubMed Web of Science ®Google Scholar
• GhajarCMPeinadoHMoriHThe perivascular niche regulates breast tumor dormancyNat Cell Boil2013157807817
   PubMed Web of Science ®Google Scholar
• CorselliMChinCJParekhCPerivascular support of human hematopoietic stem/progenitor cellsBlood2013121152891290123412095
   PubMed Web of Science ®Google Scholar
• BlissSASinhaGSandifordOAMesenchymal stem cell-derived exosomes stimulate cycling quiescence and early breast cancer dormancy in bone marrowCancer Res201676195832584427569215
   PubMed Web of Science ®Google Scholar
• OnoMKosalaNTominagaNExosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cellsSci Signal20147332ra6324985346
   PubMed Web of Science ®Google Scholar
• BartoshTJUllahMZeitouniSBeaverJProckopDJCancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs)Proc Natl Acad Sci U S A20161134264476456
   Google Scholar
• LimPKBlissSAPatelSAGap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cellsCancer Res20117151550156021343399
   PubMed Web of Science ®Google Scholar
• van den BeuckenTKochEChuKHypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICERNat Commun20142955203
   Google Scholar
• HoskinPJHypoxia dose painting in prostate and cervix cancerActa Oncol20155491259126226148050
   PubMed Web of Science ®Google Scholar
• GilkesDMImplications of hypoxia in breast cancer metastasis to boneInt J Mol Sci20161710E166927706047
   PubMedGoogle Scholar
• JohnsonRWSchipaniEGiacciaAJHIF targets in bone remodeling and metastatic diseasePharmacol Ther201515016917725681658
   PubMedGoogle Scholar
• QiuBSimonMCOncogenes strike a balance between cellular growth and homeostasisSemin Cell Dev Biol20154331026277544
   PubMedGoogle Scholar
• EckersJCKalenALSarsourEHForkhead box M1 regulates quiescence-associated radioresistance of human head and neck squamous carcinoma cellsRadiat Res2014182442042925229973
   PubMed Web of Science ®Google Scholar
• BragadoPSosaMSKeelyPCondeelisJAguirre-GhisoJAMicroenvironments dictating tumor cell dormancyRecent Results Cancer Res2012195253922527492
   PubMedGoogle Scholar
• WeidenfeldKSchif-ZuckSAbu-TayehHDormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growthOncotarget2016744713627137727655685
   PubMedGoogle Scholar
• GammonLBiddleAHeywoodHKSubsets of cancer stem cells differ intrinsically in their patterns of oxygen metabolismPLoS One201384e6249323638097
   PubMedGoogle Scholar
• ZhangHBosch-MarceMShimodaLAMitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxiaJ Biol Chem200828316108921090318281291
   PubMed Web of Science ®Google Scholar
• GammonLMackenzieICRoles of hypoxia, stem cells and epithelial-mesenchymal transition in the spread and treatment resistance of head and neck cancerJ Oral Pathol Med2016452778225952002
   PubMedGoogle Scholar
• ChenDSunYWeiYLIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic markerNat Med201218101511151723001183
   PubMed Web of Science ®Google Scholar
• IornsEWardTMDeanSWhole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressorBreast Cancer Res Treat20121351799122535017
   PubMedGoogle Scholar
• JohnsonRWFingerECOlcinaMMInduction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrowNat Cell Biol201618101078108927642788
   PubMed Web of Science ®Google Scholar
• GoniasSLHuJUrokinase receptor and resistance to targeted anticancer agentsFront Pharmacol2015615426283964
   PubMedGoogle Scholar
• AmeriKMaltepeEHIGD1A-mediated dormancy and tumor survivalMol Cell Oncol201524e103053727308509
   PubMedGoogle Scholar
• AmeriKJahangiriARajahAMHIGD1A regulates oxygen consumption, ROS production, and AMPK activity during glucose deprivation to modulate cell survival and tumor growthCell Rep2015 pii:S2211-1247150003300039
   PubMedGoogle Scholar
• HofstetterCPBurkhardtJKShinBJProtein phosphatase 2A mediates dormancy of glioblastoma multiforme-derived tumor stem-like cells during hypoxiaPLoS One201271e3005922253878
   PubMed Web of Science ®Google Scholar
• ArosioADPignataroLGainiRMGaravelloWNeck lymph node metastases from unknown primaryCancer Treat Rev2017531928027480
   PubMedGoogle Scholar
• SleemanJPThieleWTumor metastasis and the lymphatic vasculatureInt J Cancer2009125122747275619569051
   PubMedGoogle Scholar
• AchenMGStackerSAMolecular control of lymphatic metastasisAnn N Y Acad Sci2008113122523418519975
   PubMed Web of Science ®Google Scholar
• BeasleyNJPrevoRBanerjiSIntratumoral lymphangiogenesis and lymph node metastasis in head and neck cancerCancer Res20026251315132011888898
   PubMedGoogle Scholar
• OkadaYRelationship of cervical lymph node metastasis to histopathological malignancy grade, tumor angiogenesis, and lymphatic invasion in tongue cancerOdontology201098215315920652794
   PubMedGoogle Scholar
• HiratsukaSWatanabeASakuraiYThe S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phaseNat Cell Biol200810111349135518820689
   PubMed Web of Science ®Google Scholar
• AchyutBRShankarAIskanderASBone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networksCancer Lett2015369241642626404753
   PubMed Web of Science ®Google Scholar
• SleemanJSchmidAThieleWTumor lymphaticsSemin Cancer Biol200919528519482087
   PubMed Web of Science ®Google Scholar
• De CockJMShibueTDongreAKeckesovaZReinhardtFWeinbergRAInflammation triggers Zeb1-dependent escape from tumor latencyCancer Res201676236778678427530323
   PubMed Web of Science ®Google Scholar
• DaiYWangLTangJActivation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stressOncotarget2016718254782549227009858
   PubMedGoogle Scholar
• KleffelSSchattonTTumor dormancy and cancer stem cells: two sides of the same coin?Adv Exp Med Biol201373414517923143979
   PubMed Web of Science ®Google Scholar
• SansonePCeccarelliCBerishajMSelf-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancerNat Commun201671044226858125
   PubMed Web of Science ®Google Scholar
• El TounyLHVieiraAMendozaAKhannaCHoenerhoffMJGreenJECombined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cellsJ Clin Invest2014124115616824316974
   PubMedGoogle Scholar
• ZhuDWYuanYXQiaoJKEnhanced anticancer activity of a protein phosphatase 2A inhibitor on chemotherapy and radiation in head and neck squamous cell carcinomaCancer Lett20153562 pt B77378025449438
   PubMedGoogle Scholar